ANTEX BIOLOG INC has a total of 96 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are LIPOSOME CORP, NEUREX CORP and IMMTECH INT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 | |
#2 | EPO (European Patent Office) | 12 | |
#3 | Canada | 8 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Australia | 6 | |
#6 | New Zealand | 5 | |
#7 | Poland | 5 | |
#8 | Brazil | 4 | |
#9 | Argentina | 3 | |
#10 | Hungary | 3 | |
#11 | South Africa | 3 | |
#12 | China | 2 | |
#13 | Czechia | 2 | |
#14 | Hong Kong | 2 | |
#15 | Norway | 2 | |
#16 | Singapore | 2 | |
#17 | Bulgaria | 1 | |
#18 | Colombia | 1 | |
#19 | EAPO (Eurasian Patent Organization) | 1 | |
#20 | Estonia | 1 | |
#21 | Georgia | 1 | |
#22 | Japan | 1 | |
#23 | Republic of Korea | 1 | |
#24 | Latvia | 1 | |
#25 | Mexico | 1 | |
#26 | Slovakia | 1 | |
#27 | Taiwan | 1 | |
#28 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Analysing materials | |
#6 | Unspecified technologies | |
#7 | Measuring microorganism processes | |
#8 | Microorganisms | |
#9 | Microorganisms | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Tucker Kenneth | 29 |
#2 | Pace John L | 28 |
#3 | Plosila Laura | 24 |
#4 | Jackson W James | 21 |
#5 | Frey Steven M | 17 |
#6 | Walker Richard I | 16 |
#7 | Pace John Lee | 9 |
#8 | Walker Richard Ives | 9 |
#9 | Harris Andrea M | 9 |
#10 | Frey Steven Michael | 9 |
Publication | Filing date | Title |
---|---|---|
EP1409683A2 | i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF | |
US6756493B1 | Nucleic acid sequence and uses thereof | |
US6693186B2 | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
LV12233A | Receptor conjugates for targeting drugs and other agents | |
US6541616B1 | Moraxella catarrhalis protein, gene sequence and uses thereof | |
KR20000010734A | Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof | |
NZ333995A | Method and vaccine containing Helicobacter bacteria with antigenic properties | |
NZ333996A | Method and vaccine containing enteric bacteria with antigenic properties | |
BR9509276A | Processes for producing an enteric bacterium to test a potential antimicrobial agent to detect antibodies of a host to enteric bacteria and enteric bacteria in an animal or biological sample of it to produce antibacterial antibodies and to stimulate an immuno-response in an animal enteric bacteria having increased vaccine and kit antigenic properties diagnostic test to detect a host of antibodies to enteric bacteria or to detect enteric bacteria | |
US5679564A | Methods for producing enhanced antigenic campylobacter bacteria and vaccines | |
EP0598719A1 | Receptor conjugates for targeting drugs and other agents | |
EP0553113A1 | Adhesion receptors for pathogenic or opportunistic microorganisms |